Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Broadly neutralizing antibodies (bnAbs) arise in human immunodeficiency virus type 1 (HIV-1)-infected individuals to various degrees. These bnAbs represent potential components for passive immunization in humans based on the finding that they protect nonhuman primates at physiologically achievable concentrations. Long-term functional analysis of human bnAbs in nonhuman primates can be complicated by macaque immune responses against the human antibody. The AAV8 vectors can encod a simianized version of the bnAb VRC07 with and without transient immunosuppressive treatment in rhesus macaques and the efficacy of vectored bnAb immunoprophylaxis to protect against mucosal SHIV challenge.